NCT03535662View on ClinicalTrials.gov

A Pharmacokinetic Study of the Effect of Itraconazole Exposure to Orvepitant in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

June 8, 2018

Primary Completion Date

August 9, 2018

Study Completion Date

August 9, 2018

Conditions
Pharmacokinetic Study in Healthy Male Volunteers
Interventions
DRUG

Orvepitant

Single oral dose

DRUG

Itraconazole

Once daily dosing for 10 days

Trial Locations (1)

HA1 3UJ

Parexel Epcu, Harrow

Sponsors
All Listed Sponsors
lead

Nerre Therapeutics Ltd.

INDUSTRY

NCT03535662 - A Pharmacokinetic Study of the Effect of Itraconazole Exposure to Orvepitant in Healthy Volunteers | Biotech Hunter | Biotech Hunter